High Growth Tech Stocks in France to Watch October 2024
In This Article:
As the European Central Bank's recent interest rate cuts have buoyed major stock indexes, France's CAC 40 Index has seen a modest increase, reflecting a cautiously optimistic market sentiment amid ongoing monetary easing. In this environment, investors may find it beneficial to focus on high-growth tech stocks that demonstrate strong fundamentals and adaptability in a rapidly evolving economic landscape.
Top 10 High Growth Tech Companies In France
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| Icape Holding | 17.24% | 33.91% | ★★★★★☆ |
| Archos | 24.36% | 78.41% | ★★★★★☆ |
| Valneva | 22.84% | 18.29% | ★★★★★☆ |
| Valbiotis | 43.33% | 42.78% | ★★★★★☆ |
| beaconsmind | 25.00% | 85.04% | ★★★★★★ |
| Munic | 42.94% | 174.09% | ★★★★★☆ |
| Oncodesign Société Anonyme | 14.68% | 101.18% | ★★★★★☆ |
| VusionGroup | 28.35% | 81.72% | ★★★★★★ |
| Adocia | 70.20% | 63.97% | ★★★★★☆ |
| Pherecydes Pharma Société anonyme | 63.30% | 78.85% | ★★★★★☆ |
Here we highlight a subset of our preferred stocks from the screener.
OVH Groupe
Simply Wall St Growth Rating: ★★★★☆☆
Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions with a market capitalization of approximately €1.66 billion.
Operations: The company generates revenue primarily through its private cloud services (€589.61 million), followed by web cloud & other services (€185.43 million), and public cloud offerings (€169.01 million).
Amidst a challenging landscape, OVH Groupe stands out with its strategic focus on R&D, investing significantly to innovate within the cloud services sector. This dedication is reflected in their R&D expense ratio which has consistently aligned with industry growth demands. Recently, they presented at the 2024 OCP Global Summit, highlighting new advancements that promise to enhance their service offerings. Despite a volatile share price and current unprofitability, OVH's revenue is expected to grow at 9.6% annually, outpacing the French market's 5.5%. Moreover, earnings are projected to surge by an impressive 101.37% annually over the next three years as they move towards profitability—signaling potential for future stability and growth in an increasingly competitive field.
-
Navigate through the intricacies of OVH Groupe with our comprehensive health report here.
-
Gain insights into OVH Groupe's past trends and performance with our Past report.
Valneva
Simply Wall St Growth Rating: ★★★★★☆
Overview: Valneva SE is a specialty vaccine company focused on developing, manufacturing, and commercializing vaccines for infectious diseases with unmet needs, with a market cap of approximately €436.45 million.